Identifying appropriate patients for NINLARO® (ixazomib): an oral treatment option for patients with multiple myeloma
Holly Wall, RN, MSN, ACNP-BC
Takeda Oncology
The asset you are trying to access is locked. Please enter your access key to unlock.